Rebecca Ihrie
Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lateral Ventricles | 11 | 2023 | 35 | 4.090 |
Why?
| | Neural Stem Cells | 12 | 2025 | 156 | 4.080 |
Why?
| | Tuberous Sclerosis | 5 | 2025 | 55 | 3.250 |
Why?
| | Stem Cell Niche | 4 | 2021 | 54 | 2.400 |
Why?
| | Glioblastoma | 8 | 2023 | 345 | 1.840 |
Why?
| | Brain Neoplasms | 8 | 2023 | 1238 | 1.790 |
Why?
| | Hedgehog Proteins | 4 | 2018 | 195 | 1.370 |
Why?
| | Neurogenesis | 4 | 2019 | 149 | 1.130 |
Why?
| | Brain | 8 | 2024 | 2668 | 1.120 |
Why?
| | Adult Stem Cells | 3 | 2022 | 40 | 1.110 |
Why?
| | Signal Transduction | 11 | 2025 | 5079 | 1.050 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 4 | 2025 | 125 | 1.010 |
Why?
| | DNA Methylation | 3 | 2025 | 643 | 0.910 |
Why?
| | Membrane Proteins | 8 | 2011 | 1164 | 0.850 |
Why?
| | Zinc Finger Protein Gli3 | 1 | 2022 | 3 | 0.760 |
Why?
| | Oligodendrocyte Transcription Factor 2 | 1 | 2022 | 21 | 0.750 |
Why?
| | Microscopy | 1 | 2023 | 152 | 0.720 |
Why?
| | Printing, Three-Dimensional | 1 | 2021 | 95 | 0.670 |
Why?
| | Astrocytoma | 2 | 2019 | 128 | 0.660 |
Why?
| | Phosphoproteins | 4 | 2006 | 338 | 0.620 |
Why?
| | Trans-Activators | 4 | 2006 | 398 | 0.610 |
Why?
| | Cell Lineage | 4 | 2025 | 350 | 0.600 |
Why?
| | Nerve Tissue Proteins | 1 | 2022 | 596 | 0.560 |
Why?
| | Morphogenesis | 1 | 2018 | 166 | 0.560 |
Why?
| | Software | 1 | 2023 | 665 | 0.550 |
Why?
| | Flow Cytometry | 6 | 2024 | 1178 | 0.550 |
Why?
| | Carcinogenesis | 1 | 2019 | 217 | 0.540 |
Why?
| | Imaging, Three-Dimensional | 1 | 2021 | 580 | 0.540 |
Why?
| | Single-Cell Analysis | 4 | 2025 | 313 | 0.530 |
Why?
| | Glioma | 1 | 2021 | 395 | 0.530 |
Why?
| | Tumor Suppressor Protein p53 | 4 | 2006 | 528 | 0.510 |
Why?
| | Desmosomes | 3 | 2011 | 21 | 0.500 |
Why?
| | Cell Differentiation | 8 | 2025 | 1991 | 0.490 |
Why?
| | Neurons | 6 | 2020 | 1590 | 0.470 |
Why?
| | Animals | 28 | 2025 | 36940 | 0.470 |
Why?
| | Sirtuin 1 | 1 | 2014 | 30 | 0.450 |
Why?
| | Synapses | 1 | 2018 | 427 | 0.450 |
Why?
| | Mice | 21 | 2025 | 17787 | 0.410 |
Why?
| | Induced Pluripotent Stem Cells | 3 | 2025 | 248 | 0.400 |
Why?
| | Medulloblastoma | 1 | 2014 | 193 | 0.390 |
Why?
| | Cerebral Ventricles | 1 | 2011 | 52 | 0.360 |
Why?
| | Repressor Proteins | 1 | 2014 | 427 | 0.360 |
Why?
| | Proto-Oncogene Proteins | 1 | 2014 | 648 | 0.350 |
Why?
| | Cell Movement | 2 | 2011 | 967 | 0.330 |
Why?
| | Neoplasms | 6 | 2022 | 2671 | 0.320 |
Why?
| | Humans | 34 | 2025 | 137585 | 0.310 |
Why?
| | Apoptosis | 7 | 2019 | 2553 | 0.300 |
Why?
| | DNA-Binding Proteins | 2 | 2014 | 1502 | 0.300 |
Why?
| | Astrocytes | 2 | 2024 | 210 | 0.280 |
Why?
| | Smoothened Receptor | 2 | 2022 | 6 | 0.280 |
Why?
| | Stem Cells | 2 | 2011 | 594 | 0.270 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2011 | 860 | 0.260 |
Why?
| | Gene Expression Profiling | 3 | 2023 | 1774 | 0.250 |
Why?
| | Ectodermal Dysplasia | 1 | 2006 | 19 | 0.250 |
Why?
| | Image Cytometry | 2 | 2022 | 8 | 0.240 |
Why?
| | DNA Demethylation | 1 | 2025 | 3 | 0.240 |
Why?
| | Benzofurans | 1 | 2025 | 21 | 0.240 |
Why?
| | Tumor Suppressor Proteins | 2 | 2023 | 327 | 0.230 |
Why?
| | Mouth Mucosa | 1 | 2005 | 92 | 0.230 |
Why?
| | Cell Proliferation | 7 | 2025 | 2475 | 0.220 |
Why?
| | Cells, Cultured | 4 | 2022 | 4193 | 0.220 |
Why?
| | Hypercholesterolemia | 1 | 2025 | 106 | 0.220 |
Why?
| | Microglia | 2 | 2023 | 251 | 0.220 |
Why?
| | Tumor Microenvironment | 4 | 2023 | 674 | 0.220 |
Why?
| | Enhancer Elements, Genetic | 1 | 2025 | 190 | 0.210 |
Why?
| | Cell Adhesion | 5 | 2011 | 466 | 0.210 |
Why?
| | Skin | 2 | 2006 | 752 | 0.210 |
Why?
| | Blood-Brain Barrier | 1 | 2024 | 138 | 0.200 |
Why?
| | Olfactory Bulb | 2 | 2015 | 93 | 0.190 |
Why?
| | Biological Products | 1 | 2025 | 216 | 0.190 |
Why?
| | Disease Susceptibility | 2 | 2019 | 347 | 0.190 |
Why?
| | Neoplastic Stem Cells | 2 | 2021 | 399 | 0.180 |
Why?
| | Nestin | 1 | 2021 | 19 | 0.180 |
Why?
| | Chromatin | 1 | 2025 | 519 | 0.180 |
Why?
| | Atherosclerosis | 1 | 2025 | 415 | 0.170 |
Why?
| | Oligodendroglioma | 1 | 2020 | 15 | 0.170 |
Why?
| | Interneurons | 1 | 2022 | 122 | 0.170 |
Why?
| | Organoids | 1 | 2022 | 112 | 0.170 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2023 | 752 | 0.170 |
Why?
| | Cell Nucleus | 2 | 2023 | 620 | 0.170 |
Why?
| | Unsupervised Machine Learning | 1 | 2020 | 22 | 0.170 |
Why?
| | Macrophages | 2 | 2025 | 1547 | 0.170 |
Why?
| | Immunohistochemistry | 2 | 2023 | 1738 | 0.160 |
Why?
| | GTPase-Activating Proteins | 1 | 2020 | 83 | 0.160 |
Why?
| | X-Ray Therapy | 1 | 2019 | 2 | 0.160 |
Why?
| | Corpus Callosum | 2 | 2017 | 71 | 0.160 |
Why?
| | Thyroid Nuclear Factor 1 | 1 | 2019 | 16 | 0.160 |
Why?
| | Mice, Knockout | 7 | 2025 | 3015 | 0.150 |
Why?
| | Cell Line, Tumor | 4 | 2025 | 3412 | 0.150 |
Why?
| | Machine Learning | 1 | 2024 | 493 | 0.150 |
Why?
| | Animals, Newborn | 1 | 2021 | 844 | 0.150 |
Why?
| | Drug Resistant Epilepsy | 1 | 2020 | 102 | 0.150 |
Why?
| | Datasets as Topic | 1 | 2019 | 121 | 0.150 |
Why?
| | Chemoradiotherapy | 1 | 2019 | 225 | 0.140 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2019 | 1396 | 0.130 |
Why?
| | Genes, Reporter | 1 | 2017 | 269 | 0.130 |
Why?
| | Transgenes | 1 | 2017 | 180 | 0.130 |
Why?
| | Mice, Inbred C57BL | 4 | 2025 | 5757 | 0.120 |
Why?
| | Zinc Finger Protein GLI1 | 2 | 2015 | 25 | 0.120 |
Why?
| | Macrolides | 1 | 2016 | 65 | 0.120 |
Why?
| | Survival Analysis | 1 | 2019 | 1325 | 0.120 |
Why?
| | Mass Spectrometry | 1 | 2019 | 739 | 0.120 |
Why?
| | Angelman Syndrome | 1 | 2015 | 11 | 0.120 |
Why?
| | Kruppel-Like Transcription Factors | 2 | 2015 | 66 | 0.120 |
Why?
| | Proto-Oncogene Proteins c-bcl-6 | 1 | 2014 | 8 | 0.120 |
Why?
| | Genomic Imprinting | 1 | 2015 | 26 | 0.120 |
Why?
| | Epithelium | 2 | 2006 | 313 | 0.110 |
Why?
| | Kaplan-Meier Estimate | 1 | 2016 | 889 | 0.110 |
Why?
| | ErbB Receptors | 1 | 2017 | 614 | 0.110 |
Why?
| | Mutation | 1 | 2025 | 3958 | 0.110 |
Why?
| | Age Factors | 2 | 2011 | 3295 | 0.100 |
Why?
| | Oligodendroglia | 1 | 2015 | 179 | 0.100 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2015 | 175 | 0.100 |
Why?
| | Transcription Factors | 2 | 2016 | 1719 | 0.100 |
Why?
| | Phenotype | 2 | 2025 | 3196 | 0.100 |
Why?
| | Female | 8 | 2024 | 73304 | 0.100 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 69 | 0.100 |
Why?
| | Proteomics | 1 | 2019 | 1111 | 0.090 |
Why?
| | Calbindins | 1 | 2011 | 6 | 0.090 |
Why?
| | Stilbamidines | 1 | 2011 | 10 | 0.090 |
Why?
| | S100 Calcium Binding Protein G | 1 | 2011 | 8 | 0.090 |
Why?
| | Choline O-Acetyltransferase | 1 | 2011 | 24 | 0.090 |
Why?
| | Germ Layers | 1 | 2011 | 6 | 0.090 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 2011 | 72 | 0.090 |
Why?
| | Estrogen Antagonists | 1 | 2011 | 45 | 0.090 |
Why?
| | Cytarabine | 1 | 2011 | 61 | 0.090 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1692 | 0.090 |
Why?
| | Odontogenesis | 1 | 2011 | 11 | 0.090 |
Why?
| | Tomography, X-Ray Computed | 1 | 2021 | 2691 | 0.090 |
Why?
| | Dental Enamel | 1 | 2011 | 70 | 0.090 |
Why?
| | Circadian Rhythm | 1 | 2015 | 468 | 0.090 |
Why?
| | Sirolimus | 2 | 2024 | 276 | 0.090 |
Why?
| | Tamoxifen | 1 | 2011 | 202 | 0.080 |
Why?
| | Luminescent Proteins | 1 | 2011 | 179 | 0.080 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2012 | 224 | 0.080 |
Why?
| | Gene Expression | 2 | 2015 | 1502 | 0.080 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2011 | 220 | 0.080 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2012 | 872 | 0.080 |
Why?
| | Disease Progression | 1 | 2016 | 2757 | 0.070 |
Why?
| | Mice, Transgenic | 2 | 2011 | 2167 | 0.070 |
Why?
| | Heterozygote | 2 | 2006 | 293 | 0.070 |
Why?
| | Male | 6 | 2025 | 67762 | 0.070 |
Why?
| | Blotting, Northern | 2 | 2004 | 201 | 0.070 |
Why?
| | Immunosuppressive Agents | 1 | 2011 | 890 | 0.060 |
Why?
| | Child, Preschool | 2 | 2019 | 11074 | 0.060 |
Why?
| | Child | 4 | 2020 | 21935 | 0.060 |
Why?
| | Adult | 4 | 2019 | 37929 | 0.060 |
Why?
| | Papilloma | 1 | 2005 | 52 | 0.060 |
Why?
| | Hair | 1 | 2006 | 84 | 0.060 |
Why?
| | Desmoplakins | 1 | 2005 | 20 | 0.060 |
Why?
| | Genes, Tumor Suppressor | 1 | 2005 | 86 | 0.060 |
Why?
| | Epidermis | 1 | 2006 | 157 | 0.060 |
Why?
| | CpG Islands | 1 | 2025 | 157 | 0.060 |
Why?
| | Cytoskeletal Proteins | 1 | 2005 | 158 | 0.060 |
Why?
| | Structure-Activity Relationship | 1 | 2025 | 570 | 0.050 |
Why?
| | Molecular Structure | 1 | 2025 | 489 | 0.050 |
Why?
| | Blotting, Southern | 1 | 2003 | 73 | 0.050 |
Why?
| | In Situ Nick-End Labeling | 1 | 2003 | 124 | 0.050 |
Why?
| | Keratinocytes | 1 | 2005 | 249 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2004 | 139 | 0.050 |
Why?
| | Mutant Proteins | 1 | 2023 | 103 | 0.050 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2025 | 261 | 0.050 |
Why?
| | RNA, Messenger | 1 | 2011 | 2833 | 0.050 |
Why?
| | Mice, Mutant Strains | 1 | 2003 | 298 | 0.050 |
Why?
| | Phagocytes | 1 | 2023 | 101 | 0.050 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2025 | 446 | 0.050 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2607 | 0.050 |
Why?
| | Fetal Development | 1 | 2005 | 296 | 0.050 |
Why?
| | Adolescent | 2 | 2019 | 21513 | 0.050 |
Why?
| | Phagocytosis | 1 | 2023 | 380 | 0.050 |
Why?
| | Hepatocytes | 2 | 2017 | 220 | 0.040 |
Why?
| | Lymphocytes | 1 | 2023 | 397 | 0.040 |
Why?
| | Cell Separation | 2 | 2017 | 318 | 0.040 |
Why?
| | Erlotinib Hydrochloride | 1 | 2020 | 72 | 0.040 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2022 | 267 | 0.040 |
Why?
| | Microscopy, Fluorescence | 2 | 2017 | 402 | 0.040 |
Why?
| | Malformations of Cortical Development | 1 | 2020 | 13 | 0.040 |
Why?
| | Time Factors | 1 | 2011 | 6828 | 0.040 |
Why?
| | Myocardium | 1 | 2006 | 1002 | 0.040 |
Why?
| | Haploinsufficiency | 1 | 2020 | 56 | 0.040 |
Why?
| | Remission Induction | 1 | 2020 | 288 | 0.040 |
Why?
| | Antineoplastic Agents, Alkylating | 1 | 2019 | 73 | 0.040 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2019 | 43 | 0.040 |
Why?
| | Drug Resistance | 1 | 2019 | 169 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 233 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2020 | 955 | 0.040 |
Why?
| | Mice, SCID | 2 | 2012 | 367 | 0.040 |
Why?
| | Models, Biological | 1 | 2005 | 1783 | 0.040 |
Why?
| | Skin Neoplasms | 1 | 2005 | 855 | 0.030 |
Why?
| | DNA Repair | 1 | 2019 | 231 | 0.030 |
Why?
| | Amphiregulin | 1 | 2017 | 25 | 0.030 |
Why?
| | Karnofsky Performance Status | 1 | 2017 | 38 | 0.030 |
Why?
| | Transcriptome | 1 | 2023 | 971 | 0.030 |
Why?
| | Cerebral Cortex | 1 | 2020 | 433 | 0.030 |
Why?
| | Jurkat Cells | 1 | 2016 | 134 | 0.030 |
Why?
| | Leukocyte Common Antigens | 1 | 2016 | 87 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2017 | 232 | 0.030 |
Why?
| | Blotting, Western | 2 | 2012 | 1226 | 0.030 |
Why?
| | Cryopreservation | 1 | 2017 | 100 | 0.030 |
Why?
| | A549 Cells | 1 | 2016 | 66 | 0.030 |
Why?
| | Staining and Labeling | 1 | 2016 | 150 | 0.030 |
Why?
| | HLA-DR Antigens | 1 | 2016 | 228 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2017 | 390 | 0.030 |
Why?
| | Protein Transport | 1 | 2017 | 445 | 0.030 |
Why?
| | Aging | 1 | 2006 | 1864 | 0.030 |
Why?
| | Chronotherapy | 1 | 2015 | 3 | 0.030 |
Why?
| | ARNTL Transcription Factors | 1 | 2015 | 17 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1710 | 0.030 |
Why?
| | Biological Transport | 1 | 2016 | 418 | 0.030 |
Why?
| | Precision Medicine | 1 | 2019 | 429 | 0.030 |
Why?
| | Fluorescent Dyes | 1 | 2016 | 321 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2019 | 1946 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1353 | 0.030 |
Why?
| | Antigens, CD | 1 | 2016 | 521 | 0.030 |
Why?
| | Gene Deletion | 1 | 2015 | 391 | 0.030 |
Why?
| | Proteins | 1 | 2019 | 1009 | 0.020 |
Why?
| | Algorithms | 1 | 2020 | 1704 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2017 | 7635 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2015 | 1316 | 0.020 |
Why?
| | Prognosis | 1 | 2020 | 4030 | 0.020 |
Why?
| | Liver | 2 | 2015 | 1943 | 0.020 |
Why?
| | Intestinal Mucosa | 1 | 2017 | 623 | 0.020 |
Why?
| | Olfactory Pathways | 1 | 2011 | 36 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 171 | 0.020 |
Why?
| | Ameloblasts | 1 | 2011 | 1 | 0.020 |
Why?
| | Sleep Wake Disorders | 1 | 2015 | 286 | 0.020 |
Why?
| | Tooth | 1 | 2011 | 42 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2011 | 117 | 0.020 |
Why?
| | Body Weight | 1 | 2015 | 985 | 0.020 |
Why?
| | Mice, Nude | 1 | 2012 | 698 | 0.020 |
Why?
| | Piperazines | 1 | 2012 | 350 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2012 | 1272 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4295 | 0.020 |
Why?
| | Indoles | 1 | 2012 | 412 | 0.020 |
Why?
| | Pyridines | 1 | 2012 | 506 | 0.020 |
Why?
| | Sulfonamides | 1 | 2012 | 513 | 0.020 |
Why?
| | Phosphorylation | 1 | 2012 | 1759 | 0.020 |
Why?
| | Genes, Lethal | 1 | 2006 | 30 | 0.020 |
Why?
| | Keratin-15 | 1 | 2006 | 16 | 0.020 |
Why?
| | 9,10-Dimethyl-1,2-benzanthracene | 1 | 2005 | 24 | 0.020 |
Why?
| | Keratin-5 | 1 | 2006 | 50 | 0.020 |
Why?
| | Cell Growth Processes | 1 | 2005 | 52 | 0.010 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2005 | 150 | 0.010 |
Why?
| | Genes, p53 | 1 | 2005 | 72 | 0.010 |
Why?
| | Keratins | 1 | 2006 | 173 | 0.010 |
Why?
| | Carcinogens | 1 | 2005 | 125 | 0.010 |
Why?
| | Aged | 2 | 2017 | 23961 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2017 | 3566 | 0.010 |
Why?
| | Gene Silencing | 1 | 2005 | 195 | 0.010 |
Why?
| | Ki-67 Antigen | 1 | 2004 | 112 | 0.010 |
Why?
| | Neoplasm Transplantation | 1 | 2004 | 257 | 0.010 |
Why?
| | Neoplasm Invasiveness | 1 | 2004 | 510 | 0.010 |
Why?
| | DNA Replication | 1 | 2004 | 238 | 0.010 |
Why?
| | Cell Division | 1 | 2004 | 794 | 0.010 |
Why?
| | Middle Aged | 2 | 2017 | 33479 | 0.010 |
Why?
| | Heart | 1 | 2006 | 655 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2004 | 1062 | 0.010 |
Why?
| | Alleles | 1 | 2004 | 891 | 0.010 |
Why?
| | Young Adult | 1 | 2017 | 13209 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2004 | 2900 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2011 | 6079 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2017 | 15657 | 0.010 |
Why?
| | Infant | 1 | 2011 | 9465 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2005 | 2426 | 0.010 |
Why?
|
|
Ihrie's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|